These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24425586)

  • 1. Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation.
    Im E; Kim BK; Ko YG; Shin DH; Kim JS; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2014 Feb; 7(1):88-96. PubMed ID: 24425586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Clinical Outcomes of Late Stent Malapposition Detected by Optical Coherence Tomography After Drug-Eluting Stent Implantation.
    Im E; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    J Am Heart Assoc; 2019 Apr; 8(7):e011817. PubMed ID: 30905253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic characteristics of late stent malapposition after drug-eluting stents implantation by optical coherence tomography follow-up.
    Hou JB; Liu HM; Ma LJ; Yang S; Meng LB; Han ZG; Zhang S; Yu B
    Chin Med J (Engl); 2010 Mar; 123(5):581-4. PubMed ID: 20367985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
    Guo N; Maehara A; Mintz GS; He Y; Xu K; Wu X; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW
    Circulation; 2010 Sep; 122(11):1077-84. PubMed ID: 20805433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.
    Roth C; Gangl C; Dalos D; Delle-Karth G; Neunteufl T; Berger R
    J Interv Cardiol; 2018 Dec; 31(6):780-791. PubMed ID: 30479028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study.
    Radu MD; Räber L; Kalesan B; Muramatsu T; Kelbæk H; Heo J; Jørgensen E; Helqvist S; Farooq V; Brugaletta S; Garcia-Garcia HM; Jüni P; Saunamäki K; Windecker S; Serruys PW
    Eur Heart J; 2014 Mar; 35(12):795-807. PubMed ID: 24132187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography.
    Sawada T; Shite J; Shinke T; Tanino Y; Ogasawara D; Kawamori H; Kato H; Miyoshi N; Yoshino N; Hirata K
    J Cardiol; 2008 Dec; 52(3):290-5. PubMed ID: 19027609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation.
    Hong SJ; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2015 Nov; 56(6):1538-44. PubMed ID: 26446634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up.
    Kawamori H; Shite J; Shinke T; Otake H; Matsumoto D; Nakagawa M; Nagoshi R; Kozuki A; Hariki H; Inoue T; Osue T; Taniguchi Y; Nishio R; Hiranuma N; Hirata K
    Eur Heart J Cardiovasc Imaging; 2013 Sep; 14(9):865-75. PubMed ID: 23291393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography.
    Guagliumi G; Bezerra HG; Sirbu V; Ikejima H; Musumeci G; Biondi-Zoccai G; Lortkipanidze N; Fiocca L; Capodanno D; Wang W; Tahara S; Vassileva A; Matiashvili A; Valsecchi O; Costa MA
    Circ Cardiovasc Interv; 2012 Feb; 5(1):30-8. PubMed ID: 22298797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study.
    Räber L; Zanchin T; Baumgartner S; Taniwaki M; Kalesan B; Moschovitis A; Garcia-Garcia HM; Justiz J; Pilgrim T; Wenaweser P; Meier B; Jüni P; Windecker S
    Int J Cardiol; 2014 May; 173(2):259-67. PubMed ID: 24631113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Acute Stent Malapposition After Drug-Eluting Stent Implantation: Effects on Long-Term Clinical Outcomes.
    Lee SY; Im E; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    J Am Heart Assoc; 2019 Jul; 8(13):e012800. PubMed ID: 31237187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Poststent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events.
    Kim BG; Kachel M; Kim JS; Guagliumi G; Kim C; Kim IS; Lee YJ; Lee OH; Byun YS; Kim BO; Milewski K; Lee SJ; Hong SJ; Ahn CM; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2022 Jan; 15(1):126-137. PubMed ID: 34023255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.
    Taniwaki M; Radu MD; Zaugg S; Amabile N; Garcia-Garcia HM; Yamaji K; Jørgensen E; Kelbæk H; Pilgrim T; Caussin C; Zanchin T; Veugeois A; Abildgaard U; Jüni P; Cook S; Koskinas KC; Windecker S; Räber L
    Circulation; 2016 Feb; 133(7):650-60. PubMed ID: 26762519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.